108 related articles for article (PubMed ID: 10727988)
1. Expression of the CD30 antigen in non-lymphoid tissues and cells.
Dürkop H; Foss HD; Eitelbach F; Anagnostopoulos I; Latza U; Pileri S; Stein H
J Pathol; 2000 Apr; 190(5):613-8. PubMed ID: 10727988
[TBL] [Abstract][Full Text] [Related]
2. Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.
Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Bolioti S; Tsiapali M; Verettas D; Tsikouras P; Chatzimichail A; Papadopoulos N
Theor Biol Med Model; 2005 Jan; 2():1. PubMed ID: 15644135
[TBL] [Abstract][Full Text] [Related]
3. The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter.
Dürkop H; Oberbarnscheidt M; Latza U; Bulfone-Paus S; Hirsch B; Pohl T; Krause H; Hummel M; Stein H
J Pathol; 2000 Oct; 192(2):182-93. PubMed ID: 11004694
[TBL] [Abstract][Full Text] [Related]
4. CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.
Latza U; Foss HD; Dürkop H; Eitelbach F; Dieckmann KP; Loy V; Unger M; Pizzolo G; Stein H
Am J Pathol; 1995 Feb; 146(2):463-71. PubMed ID: 7856755
[TBL] [Abstract][Full Text] [Related]
5. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma.
Pallesen G; Hamilton-Dutoit SJ
Am J Pathol; 1988 Dec; 133(3):446-50. PubMed ID: 2849300
[TBL] [Abstract][Full Text] [Related]
6. CD30 in normal and neoplastic cells.
Chiarle R; Podda A; Prolla G; Gong J; Thorbecke GJ; Inghirami G
Clin Immunol; 1999 Feb; 90(2):157-64. PubMed ID: 10080826
[TBL] [Abstract][Full Text] [Related]
7. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
8. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
9. High expression of the CD30 molecule in human decidual cells.
Ito K; Watanabe T; Horie R; Shiota M; Kawamura S; Mori S
Am J Pathol; 1994 Aug; 145(2):276-80. PubMed ID: 8053487
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
11. Human embryonal tissues of all three germ layers can express the CD30 antigen. An immunohistochemical study of 30 fetuses coming after therapeutic abortions from week 8th to week 16th of gestation.
Tamiolakis D; Maroulis G; Simopoulos C; Verettas D; Papadopoulos N; Venizelos J; Lambropoulou M; Koutsougeras G; Karpouzis A; Kouskoukis C
Cesk Patol; 2006 Jan; 42(1):9-15. PubMed ID: 16506595
[TBL] [Abstract][Full Text] [Related]
12. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
13. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD30 (Ber-H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma-like carcinoma. A comparison study with anaplastic large cell lymphoma.
Kneile JR; Tan G; Suster S; Wakely PE
Histopathology; 2006 Jun; 48(7):855-61. PubMed ID: 16722935
[TBL] [Abstract][Full Text] [Related]
15. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
[TBL] [Abstract][Full Text] [Related]
16. Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas.
Iwamizu-Watanabe S; Yamashita Y; Yatabe Y; Nakamura S; Mori N
Pathol Int; 2004 Jul; 54(7):503-9. PubMed ID: 15189504
[TBL] [Abstract][Full Text] [Related]
17. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
18. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
19. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W
J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
[TBL] [Abstract][Full Text] [Related]
20. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
